Suppr超能文献

对比增强彩色多普勒靶向与 10 核系统重复活检策略在既往高级别前列腺上皮内瘤变患者中的应用。

Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.

机构信息

Department of Urology, Medical University Innsbruck, Innsbruck, Austria.

出版信息

BJU Int. 2010 Jun;105(12):1660-2. doi: 10.1111/j.1464-410X.2009.08963.x. Epub 2009 Oct 26.

Abstract

OBJECTIVE

To compare the results of contrast-enhanced colour Doppler (CECD)-targeted prostate biopsy with a systematic 10-core grey-scale biopsy scheme in patients initially diagnosed with high-grade prostatic intraepithelial neoplasia (HGPIN), as although HGPIN is thought to be a precursor to invasive adenocarcinoma, its diagnosis is no longer considered an indication for repeat prostate biopsy and patients should be followed by prostate-specific antigen levels and a digital rectal examination.

PATIENTS AND METHODS

In all, 104 patients (aged 45-78 years) diagnosed with HGPIN on initial prostate needle biopsy were referred for a repeat biopsy within 6 months. Two independent examiners evaluated each patient; one used CECD-targeted biopsy (up to five cores) into hypervascular regions in the peripheral zone only, and subsequently the second took a systematic 10-core grey-scale biopsy. Cancer detection rates of both techniques were compared.

RESULTS

Overall, 26 of the 104 men (25%) had prostate cancer in the repeated biopsy. Using the CECD technique cancer was detected in 21% (22 of 104). The positive re-biopsy rate using the systematic technique was 9.6% (10 of 104; P < 0.001). The total incidence of HGPIN with no evidence of tumour on re-biopsy was 8.7% (nine of 104). The Gleason score in all 22 cancers detected with the CECD technique varied between 6 and 8. The systematic technique detected cancers with Gleason scores of 6 or 7. There were no adverse events or complications.

CONCLUSION

CECD increased the detection rate of prostate cancer, and using fewer biopsy cores than the systematic biopsy technique in patients previously diagnosed with HGPIN.

摘要

目的

比较对比增强彩色多普勒(CECD)靶向前列腺活检与系统 10 核灰阶活检方案在最初诊断为高级别前列腺上皮内瘤变(HGPIN)患者中的结果,因为尽管 HGPIN 被认为是浸润性腺癌的前体,但不再认为其诊断是重复前列腺活检的指征,患者应通过前列腺特异性抗原水平和直肠指检进行随访。

患者和方法

共有 104 例(年龄 45-78 岁)在初次前列腺针活检中被诊断为 HGPIN 的患者在 6 个月内被转介进行重复活检。两名独立的检查者评估了每位患者;一位检查者仅使用 CECD 靶向活检(最多 5 个核心)进入外周区的高血管区域,然后第二位检查者进行系统的 10 核灰阶活检。比较了两种技术的癌症检出率。

结果

总体而言,104 名男性中有 26 名(25%)在重复活检中发现前列腺癌。使用 CECD 技术,癌症的检出率为 21%(22/104)。系统技术的阳性再活检率为 9.6%(10/104;P<0.001)。在没有肿瘤证据的情况下再次活检时,HGPIN 的总发生率为 8.7%(9/104)。所有 22 例用 CECD 技术检测到的癌症的 Gleason 评分在 6 到 8 之间。系统技术检测到 Gleason 评分 6 或 7 的癌症。没有不良事件或并发症。

结论

CECD 增加了前列腺癌的检出率,并且在先前诊断为 HGPIN 的患者中使用的活检核心数比系统活检技术少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验